Anti-IgLON5 Disease With Inaugural Bilateral Neuropapillitis

Volltext

Anti-IgLON5 Disease With Inaugural Bilateral Neuropapillitis von Demortiere, Sarah, Joubert, Bastien, Benaiteau, Marie, Hilezian, Frederic, Boutiere, Clemence, Rico, Audrey, Stolowy, Natacha, Dubois, Valerie, Audoin, Bertrand, Maarouf, Adil, Pelletier, Jean

Volltext

Factors affecting the topography of nitrous oxide‐induced neurological complications von Cruz, Eva Sole, Fortanier, Etienne, Hilezian, Frederic, Maarouf, Adil, Boutière, Clémence, Demortière, Sarah, Rico, Audrey, Delmont, Emilien, Pelletier, Jean, Attarian, Shahram, Audoin, Bertrand

Volltext

Disease Evolution in Women With Highly Active MS Who Suspended Natalizumab During Pregnancy vs Rituximab/Ocrelizumab Before Conception von Demortiere, Sarah, Maarouf, Adil, Rico, Audrey, Boutiere, Clemence, Hilezian, Frederic, Durozard, Pierre, Pelletier, Jean, Audoin, Bertrand

Volltext

Efficacy of Rituximab Outlasts B-Cell Repopulation in Multiple Sclerosis: Time to Rethink Dosing? von Claverie, Roxane, Perriguey, Marine, Rico, Audrey, Boutiere, Clemence, Demortiere, Sarah, Durozard, Pierre, Hilezian, Frederic, Dubrou, Clea, Vely, Frederic, Pelletier, Jean, Audoin, Bertrand, Maarouf, Adil

Volltext

Effect of Prior Treatment With Fingolimod on Early and Late Response to Rituximab/Ocrelizumab in Patients With Multiple Sclerosis von Graille-Avy, Lisa, Boutiere, Clemence, Rigollet, Camille, Perriguey, Marine, Rico, Audrey, Demortiere, Sarah, Durozard, Pierre, Hilezian, Frederic, Vely, Frederic, Bertault-Peres, Pierre, Pelletier, Jean, Maarouf, Adil, Audoin, Bertrand

Volltext

Facteurs affectant la présentation clinique des complications neurologiques en lien avec la consommation de protoxyde d’azote : moelle ou nerf ? von Sole-Cruz, Eva, Fortanier, Etienne, Hilezian, Frederic, Delmont, Emilien, Pelletier, Jean, Attarian, Shahram, Audoin, Bertrand

Volltext